Hu Su

Title: Hu Su - Innovator in Pharmaceutical Chemistry

Introduction

Hu Su is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important drug intermediates. His work is characterized by a focus on efficiency, safety, and environmental sustainability.

Latest Patents

One of Hu Su's key patents is titled "Method for preparing elagolix intermediate and composition thereof." This invention relates to a method for preparing an intermediate of sodium elagolix, which is crucial for the production of this pharmaceutical compound. The method boasts advantages such as simple and safe operation, high yield, reduced environmental pollution, and economic viability, making it suitable for industrial production. The patent highlights the versatility of the intermediate, represented by R, which can be C1-C4 substituted or unsubstituted benzyl or allyl.

Career Highlights

Throughout his career, Hu Su has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Zhejiang Huahai Pharmaceutical Co., Ltd. and Shanghai Syncores Technologies Inc. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in drug development.

Collaborations

Hu Su has collaborated with talented individuals in his field, including Xiaowen Guo and Yukun Liang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Hu Su's contributions to pharmaceutical chemistry, particularly through his innovative patent for synthesizing elagolix intermediates, demonstrate his commitment to advancing the field. His work not only enhances drug production processes but also emphasizes the importance of sustainability in pharmaceutical manufacturing.